Nuo Therapeutics, Inc.
AURX
$1.24
$0.010.78%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.31M | 2.61M | 1.95M | 1.62M | 1.37M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.31M | 2.61M | 1.95M | 1.62M | 1.37M |
| Cost of Revenue | 1.10M | 773.50K | 467.30K | 373.20K | 302.80K |
| Gross Profit | 2.22M | 1.84M | 1.48M | 1.24M | 1.06M |
| SG&A Expenses | 4.73M | 4.40M | 4.09M | 3.74M | 3.52M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.83M | 5.18M | 4.55M | 4.11M | 3.82M |
| Operating Income | -2.52M | -2.57M | -2.60M | -2.49M | -2.46M |
| Income Before Tax | -2.51M | -2.43M | -2.47M | -2.36M | -2.32M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.51 | -2.43 | -2.47 | -2.36 | -2.32 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.51M | -2.43M | -2.47M | -2.36M | -2.32M |
| EBIT | -2.52M | -2.57M | -2.60M | -2.49M | -2.46M |
| EBITDA | -2.43M | -2.49M | -2.55M | -2.46M | -2.43M |
| EPS Basic | -0.05 | -0.05 | -0.05 | -0.05 | -0.05 |
| Normalized Basic EPS | -0.03 | -0.03 | -0.04 | -0.03 | -0.03 |
| EPS Diluted | -0.05 | -0.05 | -0.05 | -0.05 | -0.05 |
| Normalized Diluted EPS | -0.03 | -0.03 | -0.04 | -0.03 | -0.03 |
| Average Basic Shares Outstanding | 189.24M | 188.35M | 186.43M | 184.26M | 181.69M |
| Average Diluted Shares Outstanding | 189.24M | 188.35M | 186.43M | 184.26M | 181.69M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |